.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Blogs
Clinical Trial Corner
CURE Ambassador Program
Podcasts
Publications
Recipes
Videos

Cancer TypeSee All >

Bladder
Brain
Breast
Gastrointestinal
Gynecologic
Head & Neck
Lung
Lymphoma
Myeloma
Sarcoma
Skin

About CURE

Press Releases
Share Your Story
Write for CURE

About
Advertise
Contact
TargetedOnc.com
OncLive.com
CancerNetwork.com
Terms & Conditions
Privacy
Do Not Sell My Information

Understanding PARP Inhibition in BRCA-Mutated Breast Cancer

EP. 1: Appropriately Diagnosing and Classifying Breast Cancer

December 4th 2018

EP. 2: Considering Treatment for HER2-Negative Breast Cancer

December 4th 2018

EP. 3: BRCA Mutations in HER2-Negative Breast Cancer

December 4th 2018

EP. 4: BRCA+ Breast Cancer: The Advent of PARP Inhibitors

December 4th 2018

EP. 5: Future Role of PARP Inhibition in BRCA+ Breast Cancer

December 4th 2018

EP. 6: Breaking Down the Nature of Breast Cancer

December 4th 2018

EP. 7: Breast Cancer Diagnosis: Addressing Questions and Concerns

December 4th 2018

EP. 8: Treatment Options for HER2-Negative Breast Cancer

December 4th 2018

EP. 9: Benefit of PARP Inhibitors in BRCA+ Breast Cancer

December 4th 2018

EP. 10: BRCA+ Breast Cancer: Managing Patients on PARP Inhibitors

December 4th 2018

Latest News

A Step-by-Step Guide to Cancer Genetic Testing

Experiencing Invalidation After a Stage 0 Breast Cancer Diagnosis

Long-Term Data Show The Impact of Herceptin On Treating HER2-Positive Breast Cancer

Keeping Hope in Your Back Pocket as a Patient With Cancer

View More Latest News